Barbara Weber's Net Worth
$19.2 Million
Who is Barbara Weber?
Barbara Weber has an estimated net worth of $19.2 Million. This is based on reported shares across multiple companies, which include Revolution Medicines, Inc., Tango Therapeutics, Inc., and Opy Acquisition Corp. I.
SEC CIK
Barbara Weber's CIK is 0001800670
Past Insider Trading and Trends
2020 was Barbara Weber's most active year for acquiring shares with 8 total transactions. Barbara Weber's most active month to acquire stocks was the month of May. 2020 was Barbara Weber's most active year for disposing of shares, totalling 14 transactions. Barbara Weber's most active month to dispose stocks was the month of January. 2023 saw Barbara Weber paying a total of $57,037.06 for 665,418 shares, this is the most they've acquired in one year. In 2023 Barbara Weber cashed out on 30,000 shares for a total of $526,000.50, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Revolution Medicines, Inc. (RVMD) Snapshot price: $41.84
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -9.01% | -1.81K |
$44.83 | -$81,052.64 | 18.27K |
Aug 21
| |||
Form 4/A
| +26.84% | 4.25K |
—
|
—
| 20.07K |
Jun 20
| |||
Form 4
| +30.33% | 4.8K |
—
|
—
| 20.63K |
Jun 20
| |||
Form 4
|
—
|
0
|
$19.43 | -$468,963.44 | 15.82K |
Sep 1
| |||
Form 4
| +48.94% | 5.2K |
—
|
—
| 15.82K |
Jun 8
| |||
Form 4
| +95.85% | 5.2K |
—
|
—
| 10.63K |
Jun 16
| |||
Form 4
| +200.06% | 3.62K |
—
|
—
| 5.42K |
Jun 22
| |||
Form 4
|
—
|
0
|
$27.54 | -$228,116.97 | 1.81K |
Scheduled
|
Feb 4
| ||
Form 4
|
—
|
0
|
$23.06 | -$234,143.68 | 1.81K |
Scheduled
|
Feb 2
| ||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Dec 30
| |||
Form 4
|
—
|
0
|
$21.04 | -$212,553.60 | 1.81K |
Scheduled
|
Dec 30
| ||
Form 4
|
—
|
0
|
$18.50 | -$347,593.66 | 1.81K |
Scheduled
|
Oct 1 - Oct 5
| ||
Form 4
|
—
|
0
|
$14.56 | -$53,760.00 | 1.81K |
Scheduled
|
Aug 12 - Aug 13
| ||
Form 4
|
∞
| 1.81K |
—
|
—
| 1.81K |
Jun 17
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Tango Therapeutics, Inc. (TNGX) Snapshot price: $10.89
Chief Executive Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -0.59% | -9.14K |
$12.59 | -$115,051.98 | 1.54M |
Feb 6 - Feb 7
| |||
Form 4
|
∞
| 87.17K |
—
|
—
| 87.17K |
Feb 1
| |||
Form 4
| +6.55% | 89.55K |
—
|
—
| 1.46M |
Mar 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 12
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Opy Acquisition Corp. I (OHAA) No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||